Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the safety and efficacy of two different tacrolimus
based immunosuppressive regimens, one in combination with daclizumab, the other in
combination with steroids, in recipients of suboptimal livers.
Pharmacokinetics of tacrolimus and bile composition will be measured in a subgroup of
patients.